Skip to main content
Clinical Trials/NCT06557694
NCT06557694
Completed
Not Applicable

Effect of COVID-19 Infection on Obstertric Complications and Maternal Outcomes

Tanta University1 site in 1 country260 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Tanta University
Enrollment
260
Locations
1
Primary Endpoint
Pregnancy related complications
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study aimed to evaluate the effect of COVID-19 infection on obstetric complications and maternal outcomes.

Detailed Description

During the SARS-CoV-2 pandemic, pregnant women were reported to have a higher susceptibility to COVID-19 infection. Pregnant women who tested positive for SARS-CoV-2 are at higher risk of a severe form of COVID-19, associated with higher rates of intensive care unit (ICU) admission and increased needs for respiratory support, compared to the age-matched non-pregnant population. Women infected during pregnancy also have an increased risk of adverse pregnancy outcomes including preterm-birth, with a significant proportion secondary to iatrogenic preterm birth due to maternal illness. Infection with SARS-CoV-2 during pregnancy has also been reported to be associated with a higher risk of stillbirth directly or indirectly caused by the virus. Infected pregnant patients tended to present asymptomatically with pre-Delta and Omicron variants, and symptomatically with Delta variant. A previous systematic review suggested that people who are pregnant did not have an increased risk of SARS-CoV-2 infection or symptomatic COVID-19, but they were at risk of severe COVID-19 compared with those who were not pregnant.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 1, 2022
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mai Nabil Ageez

Lecturer of Obstetrics and Gynecology, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

Eligibility Criteria

Inclusion Criteria

  • Age from 18 to 40 years.
  • Pregnant women with COVID-19 infection diagnosed either by PCR or rapid test.

Exclusion Criteria

  • Patients vaccinated for COVID-19 before or during the current pregnancy.

Outcomes

Primary Outcomes

Pregnancy related complications

Time Frame: For one month

Pregnancy related complications as preterm birth, preeclampsia, intrauterine fetal demise (IUFD), increased cesarean section rate, postpartum hemorrhagic gastroenteritis (HGE) were collected

Secondary Outcomes

  • Apgar score(For 5 minutes post-intervention)
  • Intensive care unit admission rate(For one month)
  • Use of mechanical ventilation(For one year)
  • Incidence of death(For one month)

Study Sites (1)

Loading locations...

Similar Trials